| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $151.9M | +96.2% |
| Cost of Revenue | $3.4M | +26.4% |
| R&D Expense | $207.0M | -3.5% |
| SG&A Expense | $58.9M | -6.5% |
| Operating Income | -$121.4M | +40.1% |
| Income Tax | $0 | — |
| Net Income | -$119.8M | +40.7% |
| EPS (Basic) | -$1.95 | +42.1% |
| EPS (Diluted) | -$1.95 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $108.9M | -11.8% |
| Accounts Receivable | $56.2M | +441.3% |
| Inventory | $1.5M | -66.9% |
| Current Assets | $222.2M | -20.5% |
| Total Assets | $280.5M | -16.3% |
| Current Liabilities | $48.6M | -34.8% |
| Total Liabilities | $138.5M | +44.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$87.0M | +39.5% |
| Capital Expenditures | $3.6M | -41.6% |
| Investing Cash Flow | $70.7M | +293.2% |
| Financing Cash Flow | $1.7M | -98.6% |
| Free Cash Flow | -$90.6M | +39.6% |
| +42.1% |
| Stockholders' Equity |
| $142.0M |
| -40.7% |